Skip to main content
. 2021 Jul 16;13:17588359211029825. doi: 10.1177/17588359211029825

Figure 3.

Figure 3.

Assessment of the dose–response relationship between the cumulative relative dose intensity of each FOLFIRINOX agent (csRDI) and disease control.

95%CI, 95% confidence interval estimated in a multivariable model including the csRDI of the four FOLFIRINOX agents as well as ECOG, liver metastasis, number of cycles before first reassessment and center; OR, odds ratio.